Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B LIPTON

Showing results (781-790 of 1,306) with videos related to

Pageof 131
Sort By:
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Annals of Neurology|October 1, 1993
Pathological markers associated with normal aging and dementia in the elderlyH A Crystal, D W Dickson, M J Sliwinski, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Current Pain and Headache Reports|August 6, 2014
Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experienceVijay Vishwanath, Ericka Wong, Sara C Crystal, et al.
Cephalalgia : an International Journal of Headache|February 17, 2024
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adultsRobert Croop, Rajinder Bhardwaj, Matt S Anderson, et al.
Headache|June 11, 2010
Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention StudyMarcelo E Bigal, Dawn C Buse, Ya-Ting Chen, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 14, 2022
Impact of sex and <i>APOE</i> ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adultsKellen K Petersen, Ellen Grober, Richard B Lipton, et al.
Gastroenterology|September 1, 1977
Complications of diuresis in the alcoholic patient with ascites: a controlled trialP B Gregory, P H Broekelschen, M D Hill, et al.
Pageof 131

Showing results (781-790 of 1,306) with videos related to

Sort By:
Pageof 131
Cephalalgia : an International Journal of Headache|March 27, 2007
Treatment-emergent CNS symptoms following triptan therapy are part of the attackP J Goadsby, D W Dodick, M Almas, et al.
Current Pain and Headache Reports|October 29, 2004
Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR ProjectDavid W Dodick, Richard B Lipton, Michel D Ferrari, et al.
Annals of Neurology|October 1, 1993
Pathological markers associated with normal aging and dementia in the elderlyH A Crystal, D W Dickson, M J Sliwinski, et al.
Headache|April 21, 2007
Pharmacological approaches to managing migraine and associated comorbidities--clinical considerations for monotherapy versus polytherapyStephen D Silberstein, David Dodick, Fred Freitag, et al.
Current Pain and Headache Reports|August 6, 2014
Headache in Behçet's syndrome: review of literature and NYU Behçet's syndrome center experienceVijay Vishwanath, Ericka Wong, Sara C Crystal, et al.
Cephalalgia : an International Journal of Headache|February 17, 2024
Bioequivalence of rimegepant, a small molecule CGRP receptor antagonist, administered as an oral tablet, a sublingual orally disintegrating tablet, and a supralingual orally disintegrating tablet: two phase 1 randomized studies in healthy adultsRobert Croop, Rajinder Bhardwaj, Matt S Anderson, et al.
Headache|June 11, 2010
Rates and predictors of starting a triptan: results from the American Migraine Prevalence and Prevention StudyMarcelo E Bigal, Dawn C Buse, Ya-Ting Chen, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 14, 2022
Impact of sex and <i>APOE</i> ε4 on the association of cognition and hippocampal volume in clinically normal, amyloid positive adultsKellen K Petersen, Ellen Grober, Richard B Lipton, et al.
Gastroenterology|September 1, 1977
Complications of diuresis in the alcoholic patient with ascites: a controlled trialP B Gregory, P H Broekelschen, M D Hill, et al.
Pageof 131